ZIPRASIDONE: A NEW ATYPICAL ANTIPSYCHOTIC AGENT
Ziprasidone is a benzisothiazol piperazine derivative with a higher therapeutic efficacy and a favourable tolerability profile in the treatment of schizophrenia. Ziprasidone has a high 5-HT2 to D2 receptor binding ratio and also binds with high affinity to 5-HT1A receptors. Clinical trials indicate...
Zapisane w:
| Główni autorzy: | , |
|---|---|
| Format: | Artigo |
| Język: | Inglês |
| Wydane: |
Mesut Çetin
2021-03-01
|
| Seria: | Psychiatry and Clinical Psychopharmacology |
| Hasła przedmiotowe: | |
| Dostęp online: | https://psychiatry-psychopharmacology.com/index.php/pub/article/view/289 |
| Etykiety: |
Nie ma etykietki, Dołącz pierwszą etykiete!
|